GL1X · GenesisL1 explorer

Research workbench

HCV polymerase in complex with a 1,5 benzodiazepine inhibitor

Analyse HCV polymerase in complex with a 1,5 benzodiazepine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3CSO
Type
protein
Length
1,121 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
XNI
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein56148% helix, 16% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein56049% helix, 15% strandO92972

Ligands and binding sites

  • XNI · (11S)-10-acetyl-11-[4-(benzyloxy)-3-chlorophenyl]-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111600.810.8281XNI
211650.800.8292XNI
38040.690.7576empty
41900.490.7625empty
51160.480.8017empty

Interfaces

1 interface between chains.

  • A–B · 387 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 3CSO · HCV Polymerase in complex with a 1,5 Benzodiazepine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.